Jason Law
Overview
Explore the profile of Jason Law including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joshi A, Law J, Shah N, Ghnaima H, Akanbi M, Tikaria R
Clin Case Rep
. 2024 Sep;
12(9):e9391.
PMID: 39219783
Superior vena cava syndrome (SVCS) is commonly caused by mediastinal malignancies. Early identification through clinical signs and imaging is critical to avoid complications including cerebral and laryngeal edema, and cardiogenic...
2.
Rangarajan H, Stanek J, Abdel-Azim H, Modi A, Haight A, McKinney C, et al.
Transplant Cell Ther
. 2022 Mar;
28(6):329.e1-329.e9.
PMID: 35288346
Hematopoietic cell transplantation (HCT) is the sole curative option for congenital dyserythropoietic anemia (CDA), a rare type of hemolytic anemia characterized by anemia, ineffective erythropoiesis, and secondary hemochromatosis. In this...
3.
Bona K, Brazauskas R, He N, Lehmann L, Abdel-Azim H, Ahmed I, et al.
Blood
. 2020 Oct;
137(4):556-568.
PMID: 33104215
Social determinants of health, including poverty, contribute significantly to health outcomes in the United States; however, their impact on pediatric hematopoietic cell transplantation (HCT) outcomes is poorly understood. We aimed...
4.
Hong S, Brazauskas R, Hebert K, Ganguly S, Abdel-Azim H, Diaz M, et al.
Cancer
. 2020 Oct;
127(4):609-618.
PMID: 33085090
Background: The association of community factors and outcomes after hematopoietic cell transplantation (HCT) has not been comprehensively described. Using the County Health Rankings and Roadmaps (CHRR) and the Center for...
5.
Dandoy C, Davies S, Ahn K, He Y, Kolb A, Levine J, et al.
Haematologica
. 2020 Jun;
106(7):1839-1845.
PMID: 32554562
With limited data comparing hematopoietic cell transplant outcomes between myeloablative total body irradiation (TBI) containing and non-TBI regimens in children with de novo acute myeloid leukemia, the aim of this...
6.
Inamoto Y, Petricek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, et al.
Bone Marrow Transplant
. 2019 Feb;
54(5):782-783.
PMID: 30809032
In the original version of this article, author 'Aisha Al-Khinji' was incorrectly listed as 'Aisha Ahmed'. This has now been corrected in both the PDF and HTML versions of the...
7.
Inamoto Y, Petricek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, et al.
Bone Marrow Transplant
. 2018 Dec;
54(5):648-661.
PMID: 30531955
Non-graft-vs.-host disease (non-GVHD) ocular complications are generally uncommon after hematopoietic cell transplantation (HCT), but can cause prolonged morbidity affecting activities of daily living and quality of life. Here we provide...
8.
Inamoto Y, Petricek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, et al.
Biol Blood Marrow Transplant
. 2018 Dec;
25(5):e145-e154.
PMID: 30521975
Non-graft-versus-host disease (GVHD) ocular complications are generally uncommon after hematopoietic cell transplantation (HCT) but can cause prolonged morbidity affecting activities of daily living and quality of life. Here we provide...
9.
Wood W, Brazauskas R, Hu Z, Abdel-Azim H, Ahmed I, Aljurf M, et al.
Biol Blood Marrow Transplant
. 2018 Mar;
24(9):1928-1935.
PMID: 29567340
For patients with acute lymphoblastic leukemia (ALL), allogeneic hematopoietic cell transplantation (alloHCT) offers a potential cure. Life-threatening complications can arise from alloHCT that require the application of sophisticated health care...
10.
Buchbinder D, Kelly D, Duarte R, Auletta J, Bhatt N, Byrne M, et al.
Bone Marrow Transplant
. 2018 Jan;
53(5):535-555.
PMID: 29343837
Hematopoietic cell transplantation (HCT) is a potentially curative treatment for children and adults with malignant and non-malignant diseases. Despite increasing survival rates, long-term morbidity following HCT is substantial. Neurocognitive dysfunction...